First Trust Nasdaq Pharmaceuticals ETF Rating $27.08 -0.03 (-0.11%) Closing price 07/25/2025 03:56 PM EasternExtended Trading$27.08 0.00 (0.00%) As of 07/25/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.58Holdings in FTXH have an aggregate rating of Moderate Buy based on 763 analyst ratings issued in the past year covering 49 companies (99.5% of the portfolio).FTXH Aggregate Price Target$27.08High Prediction$27.08Average Prediction$27.08Low Prediction$27.08Holdings in FTXH have an aggregate price target of $27.08 and a range of $27.08 to $27.08 covering 49 companies (99.5% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold13 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.43%JNJJohnson & Johnson$168.29-0.7%4.8404 of 5 stars2.65$174.50 3.7%20Trending NewsAnalyst Upgrade7.36%PFEPfizer$24.79-2.2%4.9812 of 5 stars2.45$28.55 15.2%22Trending NewsOptions Volume7.01%ABBVAbbVie$190.22-0.3%4.8449 of 5 stars2.81$211.29 11.1%27Trending NewsUpcoming EarningsAnalyst Revision6.89%MRKMerck & Co., Inc.$84.82+0.8%4.9947 of 5 stars2.43$108.69 28.1%21Positive NewsUpcoming EarningsDividend Announcement6.25%BMYBristol Myers Squibb$48.44-1.0%4.565 of 5 stars2.33$58.53 20.8%21Trending NewsUpcoming Earnings3.92%VTRSViatris$9.41+0.6%2.368 of 5 stars1.80$10.40 10.5%53.89%GILDGilead Sciences$116.20+2.7%4.8879 of 5 stars2.81$112.36 -3.3%26Trending NewsAnalyst Upgrade3.75%ZTSZoetis$151.92-0.6%4.9691 of 5 stars2.70$204.63 34.7%10Positive News3.62%AMGNAmgen$306.58-0.6%4.4098 of 5 stars2.35$307.27 0.2%23Positive NewsAnalyst Forecast3.61%BIIBBiogen$131.52-0.8%4.8103 of 5 stars2.34$186.37 41.7%32Upcoming EarningsAnalyst Revision3.57%UTHRUnited Therapeutics$304.50-0.6%4.991 of 5 stars2.69$383.08 25.8%13Trending NewsUpcoming EarningsInsider TradeAnalyst Revision3.39%LLYEli Lilly and Company$811.73+0.8%4.9067 of 5 stars2.75$1,012.56 24.7%20Trending NewsAnalyst Upgrade3.00%REGNRegeneron Pharmaceuticals$563.10-0.3%4.8268 of 5 stars2.75$828.86 47.2%24Trending NewsUpcoming EarningsAnalyst Forecast2.99%JAZZJazz Pharmaceuticals$118.23+0.2%4.8563 of 5 stars2.93$181.64 53.6%14Analyst Forecast2.40%EXELExelixis$45.60+1.8%4.7817 of 5 stars2.52$45.33 -0.6%21News CoveragePositive NewsUpcoming EarningsAnalyst Forecast2.35%ELANElanco Animal Health$14.92+1.6%2.6423 of 5 stars2.88$16.17 8.4%8News CoverageAnalyst Forecast2.09%CRLCharles River Laboratories International$176.85-0.1%4.4603 of 5 stars2.25$174.54 -1.3%16Positive News1.99%ILMNIllumina$109.30+1.5%4.5581 of 5 stars2.40$125.11 14.5%20Upcoming Earnings1.92%OGNOrganon & Co.$10.18+1.0%4.7712 of 5 stars2.50$18.00 76.9%61.90%MEDPMedpace$447.49-1.8%3.7182 of 5 stars2.00$411.10 -8.1%14Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap Down1.59%NBIXNeurocrine Biosciences$132.14+0.4%4.5095 of 5 stars2.88$163.87 24.0%24Upcoming EarningsAnalyst Forecast1.33%HALOHalozyme Therapeutics$58.24-0.9%4.8524 of 5 stars2.17$62.70 7.7%12Positive News1.09%BMRNBioMarin Pharmaceutical$59.01-1.3%4.9857 of 5 stars2.75$93.74 58.9%24Analyst Forecast1.03%ALKSAlkermes$26.13-1.5%4.7871 of 5 stars2.83$40.92 56.6%12Upcoming Earnings0.97%PRGOPerrigo$28.41+1.1%4.574 of 5 stars2.25$33.00 16.2%4News CoveragePositive NewsAnalyst Downgrade0.87%AMRXAmneal Pharmaceuticals$8.06+0.8%3.1436 of 5 stars3.00$11.60 43.9%50.80%PBHPrestige Consumer Healthcare$76.77+0.6%3.9051 of 5 stars2.50$93.33 21.6%6Positive News0.73%BPMCBlueprint Medicines$129.460.9484 of 5 stars2.24$128.25 -0.9%21Positive NewsUpcoming Earnings0.72%CAHCardinal Health$157.10-0.7%4.8427 of 5 stars2.79$158.07 0.6%14Positive NewsAnalyst Revision0.72%ALNYAlnylam Pharmaceuticals$328.81+0.2%4.0638 of 5 stars2.81$347.75 5.8%26News CoveragePositive NewsUpcoming Earnings0.72%CPRXCatalyst Pharmaceuticals$20.97-0.2%4.9225 of 5 stars3.25$32.83 56.6%8News CoveragePositive NewsAnalyst Revision0.68%TGTXTG Therapeutics$36.90+1.0%3.706 of 5 stars2.80$43.80 18.7%5Positive News0.68%INSMInsmed$103.95+0.4%3.9408 of 5 stars3.00$109.20 5.1%17News CoveragePositive NewsAnalyst ForecastInsider Trade0.67%CORTCorcept Therapeutics$68.29+1.0%4.8276 of 5 stars3.00$138.25 102.4%50.66%GHGuardant Health$44.42-2.4%4.4699 of 5 stars3.05$54.45 22.6%21News CoverageUpcoming EarningsAnalyst Revision0.63%EXASExact Sciences$48.49-0.6%4.7487 of 5 stars2.95$70.50 45.4%22News CoveragePositive News0.63%ACADACADIA Pharmaceuticals$23.25+0.9%4.1521 of 5 stars2.71$28.13 21.0%17Positive NewsAnalyst Forecast0.63%AKROAkero Therapeutics$50.56+0.1%3.8187 of 5 stars3.00$82.50 63.2%60.61%ADMAADMA Biologics$18.01+4.0%3.6147 of 5 stars3.33$27.67 53.6%3News CoveragePositive News0.52%INCYIncyte$70.20-0.4%4.6318 of 5 stars2.22$74.47 6.1%18Positive NewsUpcoming EarningsInsider Trade0.51%SRRKScholar Rock$38.95-0.4%3.4309 of 5 stars3.13$42.67 9.5%80.51%VRTXVertex Pharmaceuticals$469.65-0.6%4.3226 of 5 stars2.52$512.30 9.1%27Positive NewsAnalyst Revision0.50%PTCTPTC Therapeutics$44.74-3.4%4.4505 of 5 stars2.67$65.00 45.3%15News CoveragePositive News0.49%MDGLMadrigal Pharmaceuticals$298.40-0.3%4.2732 of 5 stars2.89$420.63 41.0%9News CoverageInsider Trade0.45%VCELVericel$40.12+1.0%3.689 of 5 stars3.00$61.14 52.4%7News CoveragePositive NewsUpcoming Earnings0.45%AXSMAxsome Therapeutics$100.83-3.9%4.744 of 5 stars3.06$172.33 70.9%16News CoveragePositive NewsAnalyst Revision0.44%VCYTVeracyte$25.25+7.0%3.6776 of 5 stars2.70$40.90 62.0%10News CoveragePositive NewsAnalyst UpgradeGap UpHigh Trading Volume0.43%KRYSKrystal Biotech$147.61-1.6%4.8924 of 5 stars3.00$211.33 43.2%10News CoverageAnalyst Forecast0.09%SRPTSarepta Therapeutics$11.93-7.4%4.6968 of 5 stars2.11$51.42 331.0%28Trending NewsAnalyst DowngradeGap Down This page (NASDAQ:FTXH) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTXH Stock Alerts